What approach is now AHA/ACC guideline-recommended for a patient with primary hypercholesterolemia, with an LDL-C of 192 mg/dL? Take Quiz #3.
Baxdrostat for Resistant Hypertension Meets Primary Endpoints in BAX24 Phase 3 Clinical Trial
AstraZeneca will share the positive topline 24-hour BP monitoring data with global regulatory authorities and present findings at the 2025 AHA Scientific Sessions.
Weekly Dose Podcast: Depression Risk After Chronic Illness, Vaginal Estradiol Safety, GLP-1 Updates, Cancer Risk Reduction, and Cardiovascular Outcomes
Today's episode covers depression risk after chronic illness, vaginal estradiol safety, GLP-1 updates, cancer risk, and cardiovascular outcomes.
Suboptimal Risk Factor Levels are Nearly Universal at Onset of CVD, Study of 10 Million Reveals
The binational cohort study of exposure to 4 traditional CVD risk factors over time revealed that 99% of CVD events were preceded by suboptimal levels of at least one.
Weekly Dose Podcast: CRC Screening Uptake, GLP-1 Eligibility in Youth, Women’s Heart Health, and Ultraprocessed Food Risks
This week’s podcast episode covers CRC screening, GLP-1 eligibility in youth, women’s heart health, FIT outreach, and ultraprocessed food risks.
High-Dose Flu Vaccine Cuts Myocarditis, Pericarditis Risk in Older Adults: Daily Dose
Your daily dose of the clinical news you may have missed.
Age and Aerobic Fitness Independently Linked to Atrial Arrhythmia Risk: Daily Dose